DK1955078T3 - Blodpladeaggregeringsassays - Google Patents

Blodpladeaggregeringsassays

Info

Publication number
DK1955078T3
DK1955078T3 DK06838022.9T DK06838022T DK1955078T3 DK 1955078 T3 DK1955078 T3 DK 1955078T3 DK 06838022 T DK06838022 T DK 06838022T DK 1955078 T3 DK1955078 T3 DK 1955078T3
Authority
DK
Denmark
Prior art keywords
platelet aggregation
aggregation assays
assays
platelet
aggregation
Prior art date
Application number
DK06838022.9T
Other languages
Danish (da)
English (en)
Inventor
Yen-Ming Hsu
Lihe Su
Original Assignee
Biogen Idec Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biogen Idec Inc filed Critical Biogen Idec Inc
Application granted granted Critical
Publication of DK1955078T3 publication Critical patent/DK1955078T3/da

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6863—Cytokines, i.e. immune system proteins modifying a biological response such as cell growth proliferation or differentiation, e.g. TNF, CNF, GM-CSF, lymphotoxin, MIF or their receptors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/86—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood coagulating time or factors, or their receptors

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
DK06838022.9T 2005-11-17 2006-11-17 Blodpladeaggregeringsassays DK1955078T3 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US73748805P 2005-11-17 2005-11-17
US80484306P 2006-06-15 2006-06-15
PCT/US2006/044840 WO2007059332A2 (en) 2005-11-17 2006-11-17 Platelet aggregation assays

Publications (1)

Publication Number Publication Date
DK1955078T3 true DK1955078T3 (da) 2013-09-23

Family

ID=38049325

Family Applications (1)

Application Number Title Priority Date Filing Date
DK06838022.9T DK1955078T3 (da) 2005-11-17 2006-11-17 Blodpladeaggregeringsassays

Country Status (9)

Country Link
US (2) US8409810B2 (https=)
EP (2) EP2431746A1 (https=)
JP (3) JP5396083B2 (https=)
AU (1) AU2006315274B2 (https=)
CA (1) CA2629647C (https=)
DK (1) DK1955078T3 (https=)
ES (1) ES2425571T3 (https=)
NZ (1) NZ568992A (https=)
WO (1) WO2007059332A2 (https=)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1871259A (zh) 2003-08-22 2006-11-29 比奥根艾迪克Ma公司 具有改变的效应物功能的经改进的抗体和制备它的方法
EA014226B1 (ru) 2004-07-26 2010-10-29 Байоджен Айдек Ма Инк. Антитела к cd154, их фрагменты и способы применения антител и фрагментов
PT2125894T (pt) 2007-03-22 2019-02-27 Biogen Ma Inc Proteínas de ligação incluindo anticorpos, derivados de anticorpos e fragmentos de anticorpos que se ligam especificamente ao cd154 e as suas utilizações
EP2708892B1 (de) * 2012-09-18 2015-04-15 Siemens Healthcare Diagnostics Products GmbH Verfahren zur Bestimmung Plättchen-assoziierter Analyten
PT2971039T (pt) 2013-03-14 2020-05-06 Immusoft Corp Métodos para diferenciação e transdução in vitro de células b de memória com vetores virais pseudotipados vsv-g
JP5847140B2 (ja) * 2013-08-29 2016-01-20 国立大学法人東北大学 慢性血栓塞栓性肺高血圧症の検査方法
WO2015065986A1 (en) * 2013-10-29 2015-05-07 Bloodcenter Research Foundation Method of detecting platelet activating antibodies that cause heparin-induced thrombocytopenia/thrombosis
DK3234107T3 (da) * 2014-12-19 2022-10-17 Immusoft Corp B-celler til in vivo-levering af terapeutiske midler
MA41459A (fr) 2015-02-03 2017-12-12 Als Therapy Development Inst Anticorps anti-cd40l et méthodes pour traiter des maladies ou des troubles liés aux cd40l
WO2016208948A1 (ko) * 2015-06-23 2016-12-29 서울대학교산학협력단 Cd154 결합 폴리펩타이드 및 그 용도
CN110662768B (zh) 2017-05-24 2024-01-30 Als治疗发展学会 治疗性抗cd40配体抗体

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3694161A (en) * 1971-04-14 1972-09-26 Armour Pharma Method for measuring platelet aggregation
DE4344919A1 (de) * 1993-12-30 1995-07-06 Behringwerke Ag Verfahren zur Bestimmung der Thrombozytenaggregation
US5951951A (en) * 1997-04-30 1999-09-14 Medtronic, Inc. Platelet function evaluation technique for citrated whole blood
AU8867501A (en) 2000-09-01 2002-03-13 Biogen Inc Co-crystal structure of monoclonal antibody 5c8 and cd154, and use thereof in drug design
US6500630B2 (en) 2001-01-12 2002-12-31 Mayo Foundation For Medical Education And Research Marker for inflammatory conditions
WO2002078743A1 (en) 2001-02-16 2002-10-10 University Of Rochester Compositions and methods for reducing tranfusion reactions
US6861504B2 (en) 2001-05-03 2005-03-01 Cbr, Inc. Compounds and methods for the modulation of CD154
ATE458199T1 (de) 2001-05-04 2010-03-15 Biosite Inc Diagnostische marker der akuten koronaren syndrome und ihre verwendungen
JP2005515407A (ja) * 2001-11-05 2005-05-26 ザ ブライアム アンド ウィミンズ ホスピタル インコーポレーテッド アテローム硬化症の予後マーカーとしての可溶性ｃｄ４０ｌ（ｃｄ１５４）
GB0130832D0 (en) * 2001-12-22 2002-02-06 Univ Reading Modulation of the activity of the platelet endothelial cell adhesion molecule-1 (pecam-1)
EP1587838B1 (en) * 2003-01-10 2015-04-15 Ablynx N.V. Therapeutic polypeptides, homologues thereof, fragments thereof and their use in modulating platelet-mediated aggregation
EP1530047A1 (en) * 2003-11-07 2005-05-11 Roche Diagnostics GmbH Proximal markers of arterial thrombosis and inflammation for risk stratification of coronary heart disease
US7550532B2 (en) 2005-07-11 2009-06-23 Illinois Tool Works Inc. Polyester resin composition

Also Published As

Publication number Publication date
JP2012073273A (ja) 2012-04-12
EP2431746A1 (en) 2012-03-21
ES2425571T3 (es) 2013-10-16
US9297810B2 (en) 2016-03-29
EP1955078A4 (en) 2009-09-02
US20130189713A1 (en) 2013-07-25
EP1955078A2 (en) 2008-08-13
JP2009516201A (ja) 2009-04-16
JP2014112114A (ja) 2014-06-19
JP5639993B2 (ja) 2014-12-10
NZ568992A (en) 2012-01-12
JP5396083B2 (ja) 2014-01-22
US8409810B2 (en) 2013-04-02
CA2629647C (en) 2013-05-21
EP1955078B1 (en) 2013-07-17
US20090220998A1 (en) 2009-09-03
CA2629647A1 (en) 2007-05-24
WO2007059332A2 (en) 2007-05-24
AU2006315274B2 (en) 2012-07-05
AU2006315274A1 (en) 2007-05-24
WO2007059332A3 (en) 2008-01-24

Similar Documents

Publication Publication Date Title
HRP20150176T1 (xx) Protutijela protiv miostatina
NO20076607L (no) TWEAK - bindende antistoff
DK1964852T3 (da) Anti-ilt7-antistof
DK1853310T3 (da) Anti-Abeta-antistofpræparat
DE602006006476D1 (de) Verschluss
DE602006021277D1 (de) Behälter
DE602006021279D1 (de) Behälter
EP1968994A4 (en) SYNTHETIC GENOME
DE502006006370D1 (de) Pipette
DOS2006000040S (es) Contenedor
UY3557Q (es) Envase
DE602006012066D1 (de) Daraus
NO20055587L (no) Container
DE602006021027D1 (de) Verschluss
DE602006020623D1 (de) Fälschungssicherer verschluss
EP1907751A4 (en) FOCUSABLE FOCUSABLE SURGICAL LIGHTING INTEGRATED IN THE CEILING
DE502006001178D1 (de) Pipettiervorrichtung
DE502006004903D1 (de) Kolbenhubpipette
DK1955078T3 (da) Blodpladeaggregeringsassays
DE502005005547D1 (de) Pipettiervorrichtung
DE502006008367D1 (de) Pipettiervorrichtung
FI20055498A0 (fi) Sulfonamidijohdannaisia
EP1925939A4 (en) Antibody-sensitized latex
DOS2005000217S (es) Contenedor
DE502006006842D1 (de) Behälter